Patrick A. Ott
Broad Institute(US)Boston University(US)Brigham and Women's Hospital(US)Harvard University(US)Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research, Immune cells in cancer, vaccines and immunoinformatics approaches
Most-Cited Works
- → An immunogenic personal neoantigen vaccine for patients with melanoma(2017)2,837 cited
- → Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma(2015)2,746 cited
- → Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy(2018)2,283 cited
- → A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade(2018)1,406 cited
- → Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial(2018)1,391 cited
- → Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial(2016)1,248 cited